Scale Social AI | $1,300,000 | (Nov 19, 2025)
Orion | $17,500,000 | (Nov 19, 2025)
Asseta AI | $4,200,000 | (Nov 19, 2025)
Predicta Biosciences
United States
- Cambridge, Massachusetts
- 17/07/2024
- Seed
- $5,200,000
Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.
- Industry Biotechnology Research
- Website https://www.predictabiosciences.com/
- LinkedIn https://www.linkedin.com/company/predicta-biosciences/
Related People
Kate (Gallagher) CavesFounder
United States -
Greater Boston
Executive Leader with Business Development, Corporate Development, Marketing and deep technical background in Therapeutic Development and Diagnostic tools. Passionate about the intersection of Biology, Healthcare, and AI.
Hammerhead | $10,000,000 | (Nov 19, 2025)
Condukt | $10,000,000 | (Nov 19, 2025)
Nudge Security | $22,500,000 | (Nov 19, 2025)
GetVocal AI | $26,000,000 | (Nov 19, 2025)
Cellbyte | $2,750,000 | (Nov 19, 2025)
Xenia | $12,000,000 | (Nov 19, 2025)
Venn | $52,000,000 | (Nov 19, 2025)
Planet Smart | $1,000,000 | (Nov 19, 2025)
Barker | $3,500,000 | (Nov 19, 2025)